CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 10 enrolled
Drug / intervention
Sunscreen Test Code: V53-028 +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01001975
NCT01001975Phase 3Completed

Determination of Sun Protection Factors (PFA and SPF) in Sunscreen Formulas Containing Combinations of Zinc Oxide and Avobenzone

Bayer·interventional·Posted Oct 27, 2009·Updated Mar 11, 2015

In Brief

A Phase 3 clinical trial evaluating Sunscreen Test Code: V53-028, Sunscreen Test Code: V53-030, and 1 other intervention for Sun Protection. Completed, enrolled 10 participants.

Detailed Summary

Study to determine the sunscreen protection factor (SPF) and ultraviolet A protection factor (PFA) of 2 sunscreen products containing the combination of zinc oxide and avobenzone with and without ensulizole.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSun Protection
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 27, 2009
Enrollment StartJul 1, 2009
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 16.7 years ago

Interventions

Sunscreen Test Code: V53-028drug

Sunscreen formula containing 15% Zinc Oxide, 3% Avobenzone, and 1% Ensulizole

Sunscreen Test Code: V53-030drug

Sunscreen formula containing 15% Zinc Oxide and 3% Avobenzone

Standard SPF 4 Sunscreendrug

8% Homosalate Standard SPF 4 Sunscreen